TC-N 22A

TC-N 22A is an experimental drug that is a positive allosteric modulator for the glutamate receptor mGluR4. It was developed as a potential medication for the treatment of Parkinson's disease, and has also been used as a lead compound for the development of further derivatives.^[1][2][3]

TC-N 22A

Identifiers
IUPAC name 4,5,6,8-Tetrahydro-N-2-pyridinylpyrazolo[3',4':6,7]cyclohepta[1,2]thiazol-2-amine
CAS Number	1314140-00-5
PubChem CID	46836562
IUPHAR/BPS	6231
ChemSpider	26612639
ChEMBL	ChEMBL1830707
Chemical and physical data
Formula	C14H13N5S
Molar mass	283.35 g·mol−1
3D model (JSmol)	Interactive image
SMILES C2(SC(NC4=NC=CC=C4)=N3)=C3C1=CNN=C1CCC2
InChI InChI=1S/C14H13N5S/c1-2-7-15-12(6-1)17-14-18-13-9-8-16-19-10(9)4-3-5-11(13)20-14/h1-2,6-8H,3-5H2,(H,16,19)(H,15,17,18) Key:DBISXWCOHGUFSF-UHFFFAOYSA-N